Medial EarlySign

Medial EarlySign develops machine learning-based clinical decision support tools that extract hidden predictive signals from standard electronic health record (EHR) data, enabling early detection and prevention of high-burden diseases such as cancer, diabetes, and heart failure. The company's algorithmic platform processes billions of medical data elements to generate thousands of personalized parameters, setting individualized risk levels for mass patient populations in real time. Its solutions target healthcare organizations—including large hospital systems and managed care organizations—and are validated through clinical trials across more than 5 million patients at 14 leading research institutions worldwide.